Indication: EslicarTM (Eslicarbazepine acetate) is indicated as an add-on therapy for partial seizure with or without secondary generalization. Dosage & Administration:EslicarTM(Eslicarbazepine acetate) must be added to existing anticonvulsant therapy. The recommendedstarting dose is 400 mg once dai..